Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2013; 19(2): 299-303
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.299
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.299
Table 1 Medications associated with ischemic colitis
| Agent | Mechanism |
| Amphetamines | Vasoconstriction |
| Alosetron | |
| Catecholamines (epinephrine, norepinephrine) | |
| Cocaine | |
| Cyclosporine | |
| Digitalis | |
| Dopamine | |
| Ergot derivatives | |
| Nonsteriodal anti-inflammatory drugs | |
| Pseudoephedrine | |
| Triptans (Naratriptan, Rizatriptan, Sumatriptan) | |
| Vasopressin and vasopressin analogues | |
| Glycerin enema | Local vasospasm effect |
| Phosphosoda solution | |
| Angiotensin-converting enzyme inhibitors | Systemic hypotension |
| Antipsychotic (chlorpromazine) | |
| Beta blockers | |
| Barbiturates | |
| Diuretics | |
| Interleukin-2 | |
| Tricyclic antidepressants | |
| Amphetamines | Vasculitis |
| Gold compounds | |
| Estrogens | Thrombotic lesion induction |
| Progestational agents | |
| Alosetron | Increased intracolonic pressure |
| Danazol | |
| Glycerin enema | |
| Carboplatin | Undetermined |
| Flutamide | |
| Glutaraldehyde | |
| Hyperosmotic saline laxatives | |
| Interferon-alpha | |
| Mycophenolate mofetil | |
| Paclitaxol | |
| Simvastatin | |
| Tegaserod | |
Table 2 Naranjo adverse drug reaction nomogram in our patient
| Yes | No | Our patient | |
| Are there previous conclusive reports on this reaction? | 1 | 0 | 0 |
| Did the adverse event appear after the suspected drug was administered? | 2 | -1 | 2 |
| Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered? | 1 | 0 | 1 |
| Did the adverse reaction reappear when the drug was readministered? | 2 | -1 | 2 |
| Are there alternative causes (other than the drug) that could have, on their own, caused the reaction? | -1 | 2 | 2 |
| Did the reaction appear when a placebo was given? | -1 | 1 | 1 |
| Was the drug detected in the blood (or other fluids) in concentration known to be toxic? | 1 | 0 | 0 |
| Was the reaction more severe when the dose was increased or less severe when dose was decreased? | 1 | 0 | 0 |
| Did the patient have a similar reaction to the same or similar drugs in any previous exposure? | 1 | 0 | 1 |
| Was the adverse event confirmed by any objective evidence? | 1 | 0 | 1 |
| 10 |
- Citation: Sherid M, Sifuentes H, Samo S, Deepak P, Sridhar S. Lubiprostone induced ischemic colitis. World J Gastroenterol 2013; 19(2): 299-303
- URL: https://www.wjgnet.com/1007-9327/full/v19/i2/299.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i2.299
